Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pathophysiology of MDS: genomic aberrations.

[Rinsho ketsueki] The Japanese journal of clinical hematology - 1 Jan 2016

Ichikawa Motoshi

Abstract excerpt

Myelodysplastic syndromes (MDS) are characterized by clonal proliferation of hematopoietic stem/progenitor cells and their apoptosis, and show a propensity to progress to acute myelogenous leukemia (AML). Although MDS are recognized as neoplastic diseases caused by genomic aberrations of hematopoietic cells, the details of the genetic abnormalities underlying disease development have not as yet been fully...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosome Aberrations
Share to Chromosomes, Human
Share to Epigenesis, Genetic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome, Human

Share to Genomics

Share to High-Throughput Nucleotide Sequencing

Share to Mutation

Share to Myelodysplastic Syndromes

Source

Identifiers

PMID: 27725595
DOI: 10.11406/rinketsu.57.1972

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pathophysiology of MDS: genomic aberrations.PMID 27725595Read ↗

Molecular pathophysiology of myelodysplastic syndromes.Semantic proximity Read ↗

Unraveling the molecular pathophysiology of myelodysplastic syndromes.Semantic proximity Read ↗

The genetics of myelodysplastic syndromes and the opportunities for tailored treatmentsSemantic proximity Read ↗

MDS: Recent progress in molecular pathogenesis and clinical aspects.Semantic proximity Read ↗

Pathogenesis of myelodysplastic syndromes: an overview of molecular and non-molecular aspects of the diseaseSemantic proximity Read ↗

Molecular and genetic features of myelodysplastic syndromes.Semantic proximity Read ↗

Recent advances in myelodysplastic syndromes: Molecular pathogenesis and its implications for targeted therapies.Semantic proximity Read ↗

Genetic and epigenetic pathways in myelodysplastic syndromes: A brief overview.Semantic proximity Read ↗

Molecular Pathogenesis and Treatment of Myelodysplastic Syndromes.Semantic proximity Read ↗

The genetic and molecular pathogenesis of myelodysplastic syndromes.Semantic proximity Read ↗

Myelodysplastic syndromes: molecular pathogenesis and genomic changes.Semantic proximity Read ↗

The Genomics of Myelodysplastic Syndromes: Origins of Disease Evolution, Biological Pathways, and Prognostic Implications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.